PRKAR2A anticorps

N° du produit ABIN272166

Détail du produit anti-PRKAR2A anticorps

Antigène: PRKAR2A (Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha (PRKAR2A))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PRKAR2A est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Specificité: This antibody detects endogenous levels of PKA IIα reg protein. (region surrounding Pro68)

Réactivité croisée (Details): Species reactivity (tested):Human.

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen

Pureté: > 95 % pure by SDS-PAGE

Information d'application

Indications d'application: ELISA: 1: 1000approx. 1: 5000. WB: 1: 500approx. 1: 1000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Concentration: 1,0 mg/mL

Buffer: Phosphate buffered saline (PBS), pH 7.2., 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: DO NOT FREEZE!

Stock: 4 °C

Stockage commentaire: Store the antibody undiluted at 2-8 °C.

Détails sur PRKAR2A

Antigène: PRKAR2A (Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha (PRKAR2A))

Autre désignation: PRKAR2A (PRKAR2A Produits)

Synonymes: anticorps PKR2, anticorps PRKAR2, anticorps prkar2a, anticorps zgc:85886, anticorps PRKAR2A, anticorps 1110061A24Rik, anticorps AI317181, anticorps AI836829, anticorps RII(alpha), anticorps protein kinase cAMP-dependent type II regulatory subunit alpha, anticorps protein kinase, cAMP-dependent, regulatory, type II, alpha, B, anticorps protein kinase, cAMP-dependent, regulatory, type II, alpha, anticorps protein kinase, cAMP dependent regulatory, type II alpha, anticorps protein kinase cAMP-dependent type 2 regulatory subunit alpha, anticorps PRKAR2A, anticorps prkar2ab, anticorps Prkar2a

Sujet: The second messenger cyclic AMP (cAMP) mediates diverse cellular responses to external signals such as proliferation, ion transport, regulation of metabolism and gene transcription by activation of the cAMP-dependent protein kinase (cAPK or PKA). Activation of PKA occurs when cAMP binds to the two regulatory subunits of the tetrameric PKA holoenzyme resulting in release of active catalytic subunits. Three catalytic (C) subunits have been identified, designated Cα, Cβ and Cγ, that each represent specific gene products. Cα and Cβ are closely related (93 % amino acid sequence similarity), where as Cγ displays 83 % and 79 % similarity to Cα and Cβ, respectively. Activation of transcription upon elevation of cAMP levels results from translocation of PKA to the nucleus where it phosphorylates the transcription factor cAMP response element binding protein (CREB) on serine 133 which in turn leads to TFIIB binding to TATA-box-binding protein TBP1, thus linking phospho-CREB to the pol II transcription initiation complex.Synonyms: PKA R2, PKA RII, PKR2, PRKAR2, cAMP-dependent protein kinase type II-alpha regulatory subunit, protein kinase A RII-alpha

Poids moléculaire: approx. 45 kDa

ID gène: 5576

NCBI Accession: NP_004148

UniProt: P13861

Pathways: Signalisation Hedgehog, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2